Mouse PSMA / FOLH1 Protein, His Tag (active enzyme) (MALS verified)
分子別名(Synonym)
FOLH1,PSMA,GIG27,FOLH,NAALAD1,PSM,NAALADase I,GCPII,FGCP
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Mouse PSMA, His Tag (PSA-M5245) is expressed from human 293 cells (HEK293). It contains AA Ile 44 - Ala 752 (Accession # O35409-1).
Predicted N-terminus: His
蛋白結(jié)構(gòu)(Molecular Characterization)
![1.jpg 1.jpg](/SupplyImg1/2025-01-21/6387306287069648399005621.jpg)
This protein carries a polyhistidine tag at the N-terminus.
The protein has a calculated MW of 81.5 kDa. The protein migrates as 90-100 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in MES and NaCl with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
![2.jpg 2.jpg](/SupplyImg1/2025-01-21/6387306288443152718909007.jpg)
背景(Background)
前列腺特異性膜抗原(PSMA)也被稱為葉酸水解酶1(FOLH1)、谷氨酸羧肽酶2(GCP2)、N-乙酰化α連接酸性二肽酶I(NAALAD1),屬于肽酶M28家族和M28B亞家族。FOLH1/PSMA在pH值大于6.5時(shí)是穩(wěn)定的。FOLH1/PSMA是一種II型跨膜鋅金屬肽酶,在神經(jīng)系統(tǒng)、前列腺、腎臟和小腸中表達(dá)最高。FOLH1/GCP-2是同二聚體,每個(gè)亞基結(jié)合2個(gè)鋅離子,是NAA酶活性所必需的。PSMA的催化活性涉及釋放未取代的C末端谷氨酰殘基,通常來自Ac-Asp-Glu或酰基聚γ-谷氨酸酯。FOLH1/GCP-2/PSMA具有葉酸水解酶和N-乙?;?/span>-α-連接-酸性二肽酶(NAALA酶)活性,并偏愛三α谷氨酸肽。GCP-2/PSMA參與前列腺腫瘤進(jìn)展,并表現(xiàn)出二肽基肽酶IV型活性。在體外,切割Gly-Pro-AMC。
關(guān)鍵字: PSMA;PSMA蛋白;PSMA重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。